Published in Am J Med on August 01, 1998
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol (2011) 5.06
Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. CMAJ (2003) 3.73
Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol (2009) 3.40
Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am (2007) 2.17
Individualized medical decision making: necessary, achievable, but not yet attainable. Arch Intern Med (2010) 2.01
The impact of venous thromboembolism on risk of death or hemorrhage in older cancer patients. J Gen Intern Med (2007) 1.70
Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry. Blood (2014) 1.61
Should anticoagulation be resumed after intracerebral hemorrhage? Cleve Clin J Med (2010) 1.53
Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study. J Am Geriatr Soc (2006) 1.51
Bleeding Risk Index in an anticoagulation clinic. Assessment by indication and implications for care. J Gen Intern Med (2005) 1.48
The quality of warfarin prescribing and monitoring in Veterans Affairs nursing homes. J Am Geriatr Soc (2010) 1.42
Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs. J Gastroenterol (2017) 1.36
Warfarin reversal. J Clin Pathol (2004) 1.33
Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study. Circ Cardiovasc Qual Outcomes (2009) 1.29
Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation). J Am Coll Cardiol (2013) 1.20
Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk. Front Neurol (2012) 1.14
Venous thromboembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study. Thromb Haemost (2009) 1.09
Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician. J Thromb Thrombolysis (2011) 1.08
A population-based study of inferior vena cava filters in patients with acute venous thromboembolism. Arch Intern Med (2010) 1.04
Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial. CMAJ (2007) 1.03
EDUC'AVK: reduction of oral anticoagulant-related adverse events after patient education: a prospective multicenter open randomized study. J Gen Intern Med (2008) 1.03
Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis. Circulation (2015) 1.02
Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism. J Gen Intern Med (2014) 1.02
Application of a decision support tool for anticoagulation in patients with non-valvular atrial fibrillation. J Gen Intern Med (2008) 1.01
Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies. Thromb Haemost (2003) 0.99
Bleeding and stroke risk in a real-world prospective primary prevention cohort of patients with atrial fibrillation. Chest (2011) 0.98
Use of warfarin in long-term care: a systematic review. BMC Geriatr (2012) 0.98
Updates on the clinical evidenced herb-warfarin interactions. Evid Based Complement Alternat Med (2014) 0.98
A project to improve the management of patients on warfarin in a primary care setting through the introduction of a POC analysis. BMJ Qual Improv Rep (2016) 0.91
Cardiac crossroads: deciding between mechanical or bioprosthetic heart valve replacement. Patient Prefer Adherence (2011) 0.91
Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study. BMC Health Serv Res (2008) 0.91
Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS. Kidney Int (2013) 0.89
Safe use of antithrombotics for stroke prevention in atrial fibrillation: consideration of risk assessment tools to support decision-making. Ther Adv Drug Saf (2014) 0.89
The AIMS65 Score Is a Useful Predictor of Mortality in Patients with Nonvariceal Upper Gastrointestinal Bleeding: Urgent Endoscopy in Patients with High AIMS65 Scores. Clin Endosc (2015) 0.89
Patient reported receipt of medication instructions for warfarin is associated with reduced risk of serious bleeding events. J Gen Intern Med (2008) 0.89
Assessing bleeding risk in patients taking anticoagulants. J Thromb Thrombolysis (2013) 0.88
Predicting the risk of venous thromboembolism recurrence. Am J Hematol (2012) 0.88
Drug adherence in patients taking oral anticoagulation therapy. Clin Res Cardiol (2013) 0.87
Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis. Thromb Haemost (2004) 0.86
Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial. BMC Cardiovasc Disord (2013) 0.86
Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy. World J Cardiol (2011) 0.85
Long-Term Costs of Ischemic Stroke and Major Bleeding Events among Medicare Patients with Nonvalvular Atrial Fibrillation. Cardiol Res Pract (2012) 0.84
Simultaneous intrahepatic and subgaleal hemorrhage in antiphospholipid syndrome following anticoagulation therapy. World J Gastroenterol (2013) 0.83
Mechanical circulatory support for elderly heart failure patients. Heart Fail Rev (2012) 0.83
Unexpected effects of unintended consequences: EMR prescription discrepancies and hemorrhage in patients on warfarin. AMIA Annu Symp Proc (2011) 0.82
Reversal of warfarin-induced hemorrhage in the emergency department. West J Emerg Med (2011) 0.82
Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients. Am Heart J (2012) 0.81
Anticoagulant treatment at a specialized outpatient anticoagulant therapy unit, a descriptive study. Thromb J (2005) 0.81
Untreated atrial fibrillation in the United Kingdom: Understanding the barriers and treatment options. J Saudi Heart Assoc (2014) 0.80
Edoxaban: A Comprehensive Review of the Pharmacology and Clinical Data for the Management of Atrial Fibrillation and Venous Thromboembolism. Cardiol Ther (2016) 0.80
Complication of warfarin therapy presenting as empyema. J Thorac Dis (2011) 0.80
Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage. Korean Circ J (2009) 0.79
Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin. Am J Cardiol (2015) 0.79
Atrial fibrillation and thromboprophylaxis in heart failure: the need for patient-centered approaches to address adherence. Vasc Health Risk Manag (2013) 0.79
Current strategies to minimize the bleeding risk of warfarin. J Blood Med (2013) 0.79
Bleeding incidence with concomitant use of antidepressants and warfarin. Ther Drug Monit (2011) 0.79
Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban-treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding. Acad Emerg Med (2016) 0.79
[Accidents to AVK: a retrospective study of 30 cases]. Pan Afr Med J (2012) 0.78
Influence of regular physical activity on warfarin dose and risk of hemorrhagic complications. Pharmacotherapy (2014) 0.78
Warfarin for prevention of thrombosis among long-term care residents with atrial fibrillation: evidence of continuing low use despite consideration of stroke and bleeding risk. Drugs Aging (2013) 0.78
Development of a tool to improve the quality of decision making in atrial fibrillation. BMC Med Inform Decis Mak (2011) 0.78
Risk Factors for Bleeding in Hospitalized at Risk Patients With an INR of 5 or More Treated With Vitamin K Antagonists. Medicine (Baltimore) (2015) 0.78
Primary prevention of venous thromboembolism in elderly medical patients. Clin Interv Aging (2008) 0.78
[Atrial fibrillation and thromboprophylaxis in elderly patients]. Z Kardiol (2005) 0.78
Factors affecting time to maintenance dose in patients initiating warfarin. Pharmacoepidemiol Drug Saf (2014) 0.77
Bleeding complications associated with warfarin treatment in ischemic stroke patients with atrial fibrillation: a population-based cohort study. J Stroke Cerebrovasc Dis (2013) 0.77
Comparison of the Risk of Gastrointestinal Bleeding among Different Statin Exposures with Concomitant Administration of Warfarin: Electronic Health Record-Based Retrospective Cohort Study. PLoS One (2016) 0.77
Prevention of stroke in patients with atrial fibrillation: anticoagulant and antiplatelet options. J Interv Card Electrophysiol (2012) 0.77
Oral anticoagulant-associated intracerebral hemorrhage. J Neurol (2011) 0.77
Study on Impact of Clinical Pharmacist's Interventions in the Optimal Use of Oral Anticoagulants in Stroke Patients. Indian J Pharm Sci (2013) 0.77
Venous thromboembolism: Predicting recurrence and the need for extended anticoagulation. Vasc Med (2015) 0.77
Prevention and treatment of venous thromboembolism in the elderly patient. Clin Interv Aging (2007) 0.77
Antithrombotic therapy for the treatment of atrial fibrillation in the elderly. J Interv Card Electrophysiol (2009) 0.77
The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment. PLoS One (2015) 0.76
Pharmacogenetic association study of warfarin safety endpoints in Puerto Ricans. P R Health Sci J (2014) 0.76
Should symptomatic, isolated distal deep vein thrombosis be treated with anticoagulation? Int J Angiol (2009) 0.76
Stroke Prevention in Atrial Fibrillation. J Atr Fibrillation (2010) 0.75
Anticoagulation in Heart Failure: a Review. J Atr Fibrillation (2015) 0.75
Anticoagulation in Heart Failure: a Review. J Atr Fibrillation (2015) 0.75
Anemia: An Independent Predictor Of Adverse Outcomes In Older Patients With Atrial Fibrillation. J Atr Fibrillation (2016) 0.75
Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance. Vasc Health Risk Manag (2013) 0.75
Predicting prolonged dose titration in patients starting warfarin. Pharmacoepidemiol Drug Saf (2016) 0.75
Diagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice Guidelines. Vasc Specialist Int (2016) 0.75
Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical Practice. Medicine (Baltimore) (2015) 0.75
Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists. PLoS One (2016) 0.75
Preventing stroke in atrial fibrillation patients - clinical utility of oral anticoagulants. J Blood Med (2012) 0.75
Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis. Thromb J (2012) 0.75
A role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study. BMC Health Serv Res (2011) 0.75
Emerging Tools for Stroke Prevention in Atrial Fibrillation. EBioMedicine (2016) 0.75
Assessing bleeding risk in 4824 Asian patients with atrial fibrillation: The Beijing PLA Hospital Atrial Fibrillation Project. Sci Rep (2016) 0.75
Spontaneous and non-spontaneous bleeding complications in patients with oral vitamin K antagonist therapy. Langenbecks Arch Surg (2013) 0.75
[Antithrombotic therapy in atrial fibrillation: when vitamin K antagonists? When aspirin? When heparin? When combinations of anticoagulant and antiplatelet drugs?]. Herzschrittmacherther Elektrophysiol (2009) 0.75
[Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists]. Wien Med Wochenschr (2008) 0.75
A survey of pediatric cardiology nurses' understanding of warfarin therapy. Pediatr Cardiol (2006) 0.75
Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization. JAMA (2001) 6.02
Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA (1994) 5.10
Severity-adjusted mortality and length of stay in teaching and nonteaching hospitals. Results of a regional study. JAMA (1997) 4.44
Relation between symptoms of depression and health status outcomes in acutely ill hospitalized older persons. Ann Intern Med (1997) 3.76
Doctors, drug companies, and gifts. JAMA (1990) 3.08
Functional outcomes of acute medical illness and hospitalization in older persons. Arch Intern Med (1996) 2.74
A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Ann Intern Med (2000) 2.73
Measuring prognosis and case mix in hospitalized elders. The importance of functional status. J Gen Intern Med (1997) 2.42
When doctors marry doctors: a survey exploring the professional and family lives of young physicians. Ann Intern Med (1999) 2.37
Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol (1996) 2.26
Effects of a multicomponent intervention on functional outcomes and process of care in hospitalized older patients: a randomized controlled trial of Acute Care for Elders (ACE) in a community hospital. J Am Geriatr Soc (2000) 2.20
Acceptance of external funds by physician organizations: issues and policy options. J Gen Intern Med (1995) 2.20
Lumbar interbody fusion using the Brantigan I/F cage for posterior lumbar interbody fusion and the variable pedicle screw placement system: two-year results from a Food and Drug Administration investigational device exemption clinical trial. Spine (Phila Pa 1976) (2000) 2.16
Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation? J Gen Intern Med (1996) 2.13
Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation. J Gen Intern Med (1996) 2.10
A cost analysis of topical drug regimens for dermatophyte infections. JAMA (1994) 2.03
Hospital admission risk profile (HARP): identifying older patients at risk for functional decline following acute medical illness and hospitalization. J Am Geriatr Soc (1996) 2.02
Primary care physician recommendations for colorectal cancer screening. Patient and practitioner factors. Arch Intern Med (1997) 1.99
DRONC, an ecdysone-inducible Drosophila caspase. Proc Natl Acad Sci U S A (1999) 1.94
'Brain death' and organ retrieval. A cross-sectional survey of knowledge and concepts among health professionals. JAMA (1989) 1.93
Surgery for colorectal cancer: Race-related differences in rates and survival among Medicare beneficiaries. Am J Public Health (1996) 1.83
Depressive symptoms and 3-year mortality in older hospitalized medical patients. Ann Intern Med (1999) 1.64
Failure to limit quantities of benzodiazepine hypnotic drugs for outpatients: placing the elderly at risk. Am J Med (1990) 1.57
Effects of functional status changes before and during hospitalization on nursing home admission of older adults. J Gerontol A Biol Sci Med Sci (1999) 1.56
The annual guide to "America's best hospitals". Evidence of influence among health care leaders. J Gen Intern Med (1996) 1.52
Health status versus quality of life in older patients: does the distinction matter? Am J Med (1999) 1.50
Outcomes of warfarin therapy: lessons from the real world. Mayo Clin Proc (1995) 1.43
Debcl, a proapoptotic Bcl-2 homologue, is a component of the Drosophila melanogaster cell death machinery. J Cell Biol (2000) 1.43
A new diagnostic index for predicting cervical infection with either Chlamydia trachomatis or Neisseria gonorrhoeae. J Gen Intern Med (1990) 1.40
Nurse practitioners in a teaching hospital. Nurse Pract (1995) 1.39
Doctors, drug companies and gifts. R I Med J (1991) 1.38
The relation between health status changes and patient satisfaction in older hospitalized medical patients. J Gen Intern Med (1998) 1.35
Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med (1987) 1.29
Long-term outcomes of deep-vein thrombosis. Arch Intern Med (1995) 1.26
Justification for a new cohort study of people aging with and without HIV infection. J Clin Epidemiol (2001) 1.24
The relationship between clinical assessments of nutritional status and adverse outcomes in older hospitalized medical patients. J Am Geriatr Soc (1999) 1.22
Improving functional outcomes in older patients: lessons from an acute care for elders unit. Jt Comm J Qual Improv (1998) 1.16
What patients should ask of consumers' guides to health care quality. Eval Health Prof (1998) 1.16
DECAY, a novel Drosophila caspase related to mammalian caspase-3 and caspase-7. J Biol Chem (1999) 1.16
A national population-based study of incidence of colorectal cancer and age. Implications for screening in older Americans. Cancer (1995) 1.12
A medical unit for the acute care of the elderly. J Am Geriatr Soc (1994) 1.11
Do acute care for elders units increase hospital costs? A cost analysis using the hospital perspective. J Am Geriatr Soc (1997) 1.11
Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease. J Invest Dermatol (1997) 1.08
Assessing the preventability of emergency hospital admissions. A method for evaluating the quality of medical care in a primary care facility. Am J Med (1987) 1.03
Characterization of the Drosophila caspase, DAMM. J Biol Chem (2001) 1.02
Predicting future functional status for seriously ill hospitalized adults. The SUPPORT prognostic model. Ann Intern Med (1995) 1.01
A prognostic model for patients with end-stage liver disease. Gastroenterology (1997) 0.99
Evaluation of a treatment limitation policy with a specific treatment-limiting order page. Arch Intern Med (1994) 0.98
Anticoagulants in older patients. A safety perspective. Drugs Aging (1995) 0.96
Development and validation of the Nursing Severity Index. A new method for measuring severity of illness using nursing diagnoses. Nurses of University Hospitals of Cleveland. Med Care (1992) 0.94
Sexual behavior, knowledge, and attitudes about AIDS among college freshmen. Am J Prev Med (1992) 0.94
Is economic hardship on the families of the seriously ill associated with patient and surrogate care preferences? SUPPORT Investigators. Arch Intern Med (1996) 0.93
Factors associated with the use of flexible sigmoidoscopy as a screening test for the detection of colorectal carcinoma by primary care physicians. Cancer (1998) 0.90
An index of symptoms for infection with human immunodeficiency virus: reliability and validity. J Clin Epidemiol (1994) 0.88
Clinical intervention trials: the ACE unit. Clin Geriatr Med (1998) 0.88
Clomiphene-responsive hypogonadism in sickle cell anemia. Ann Intern Med (1983) 0.86
The safety and efficacy of the Isola Spinal Implant System for the surgical treatment of degenerative disc disease. A prospective study. Spine (Phila Pa 1976) (1996) 0.82
Myc--what we have learned from flies. Curr Drug Targets (2009) 0.81
Prognostic factors in acquired immunodeficiency syndrome. J Gen Intern Med (1988) 0.80
Outcomes-based trial of an inpatient nurse practitioner service for general medical patients. J Eval Clin Pract (2001) 0.80
Do older Medicare patients cost hospitals more? Evidence from an academic medical center. Arch Intern Med (1993) 0.79
Developing guidelines for local use: algorithms for cost-efficient outpatient management of cardiovascular disorders in a VA Medical Center. Jt Comm J Qual Improv (1994) 0.79
Methylprednisolone and isoproterenol inhibit airway smooth muscle proliferation by separate and additive mechanisms. Life Sci (1996) 0.79
Diagnostic judgments of nurse practitioners providing primary gynecologic care: a quantitative analysis. J Gen Intern Med (1992) 0.78
Percent body fat in obese white females predicted by anthropometric measurements. Am J Clin Nutr (1991) 0.77
The relation of chlamydial infection of the cervix to time elapsed from the onset of menses. J Clin Epidemiol (1990) 0.77
Delivery of preventive services to older black patients using neighborhood health centers. J Am Geriatr Soc (2000) 0.76
Preventing disability in older people with chronic disease: what is a doctor to do? J Am Geriatr Soc (1998) 0.76
Social validation of component behaviors of following instructions, accepting criticism, and negotiating. J Appl Behav Anal (1992) 0.75
Atrial fibrillation and stroke: what we know, what's new, and what we should do now. CMAJ (1997) 0.75
Different strokes for different folks: are differences in physician practices good for older persons with diabetes? Med Care (2000) 0.75
Examining older people for carotid bruits: listen to your patient, not her neck. J Gen Intern Med (1998) 0.75
Drug companies and information about drugs: recommendations for doctors. Characteristics of materials distributed by drug companies: four points of view. J Gen Intern Med (1996) 0.75
Outcomes in SUPPORT. J Clin Epidemiol (1990) 0.75
Cultures of skin biopsy tissue from immunocompromised patients with cancer and rashes. Arch Dermatol (1995) 0.75
Rashes in immunocompromised cancer patients. The diagnostic yield of skin biopsy and its effects on therapy. Arch Dermatol (1993) 0.75
Reports by patients and dermatologists of skin cancer preventive services provided in dermatology offices. Arch Dermatol (1998) 0.75
The practice of TSE among college men: effectiveness of an educational program. Oncol Nurs Forum (1988) 0.75
Health services research and the endocrinologist. Endocrinol Metab Clin North Am (1997) 0.75
Ontogeny of beta-adrenergic desensitization in rabbit tracheal smooth muscle. Pediatr Pulmonol (1996) 0.75
Using the biopsychosocial model in practice. Improving the care of patients with late-life depression. J Gen Intern Med (1996) 0.75
Predictive validity of the Nursing Severity Index in patients with musculoskeletal disease. Nurses of University Hospitals of Cleveland. J Clin Epidemiol (1995) 0.75
A patient-centered model of acute care for elders. Nurs Clin North Am (1998) 0.75
Use of hematopoietic growth factors to control myelosuppression caused by radioimmunotherapy. Cancer Res (1990) 0.75